Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis

Completed · Phase 2 · Has a placebo group

Conditions studied: Arthritis, Rheumatoid

In brief

The purpose of this study is to determine the effectiveness and safety, over 6 months, of 6 dose regimens of CP-690,550, combined with methotrexate, for the treatment of adults with active rheumatoid arthritis.

Key facts

Study ID

NCT00413660

Run by

Pfizer

People needed

509

Starts

2007-01-01

Expected to finish

2008-08-01

Last updated by the study team

2013-01-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Active rheumatoid arthritis
• Inadequate response to stably dosed methotrexate

You may not qualify if…

• Current therapy with any DMARD or biologic other than methotrexate

Where it is running

• Pfizer Investigational Site — Hot Springs, Arkansas, United States
• Pfizer Investigational Site — Upland, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Newark, Delaware, United States
• Pfizer Investigational Site — DeBary, Florida, United States
• Pfizer Investigational Site — Lake Mary, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Orlando, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Zephyrhills, Florida, United States
• Pfizer Investigational Site — Rockford, Illinois, United States
• Pfizer Investigational Site — Rockford, Illinois, United States
• Pfizer Investigational Site — Dubuque, Iowa, United States
• Pfizer Investigational Site — Frederick, Maryland, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Albany, New York, United States
• Pfizer Investigational Site — Binghamton, New York, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States
• Pfizer Investigational Site — Raleigh, North Carolina, United States
• Pfizer Investigational Site — Dayton, Ohio, United States
• Pfizer Investigational Site — Philladelphia, Pennsylvania, United States
• Pfizer Investigational Site — West Reading, Pennsylvania, United States
• Pfizer Investigational Site — Greenville, South Carolina, United States
• Pfizer Investigational Site — Austin, Texas, United States
• Pfizer Investigational Site — Gilbert, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.